Cloud-based software solutions provider Callidus Software (News - Alert) Inc. has announced that a prominent biopharmaceutical company has selected CallidusCloud's Commissions. The CallidusCloud solution replaces an existing sales compensation management system to provide greater flexibility in the management of the compensation and bonus plans for the North American sales teams. The agreement was signed in the third quarter of 2012, said the company.
Callidus, which now does business as CallidusCloud, offers solutions that enable organizations to drive performance and productivity across their business with the company’s hiring, learning, marketing and selling clouds. From back office to the field, from desktop to mobile, Callidus Cloud’s goal is to ensure that organizations have the right tools to be more effective and perform better.
"This new contract underscores the importance of having a configurable, easy to maintain cloud solution to drive true sales performance," said Eric Brown, VP, North America Sales, CallidusCloud, in a statement.
"The biopharmaceutical industry is a complex and rapidly changing marketplace. It is of paramount importance that the compensation process is automated and flexible. This competitive replacement highlights the desire of customers, across all industries, to avoid lengthy consulting exercises while maintaining the ability to carry out vital plan changes by themselves,” he added.
CallidusCloud's Commissions enables companies to deploy targeted incentives and commission programs to drive sales execution. It provides businesses with the ability to automate the calculation and payment of commissions across internal and external sales.
With extensive modeling and analytics capabilities, the solution provides clear insight into the performance of current plans as well as a highly accurate forecast of future performance. Sales operations and finance enjoy significant time and cost savings whilst sales teams enjoy faster, more accurate and more transparent commission payments, said the company.
Edited by Brooke Neuman